What can I claim secondary to cirrhosis of the liver?
17 conditions in the Repatriation Medical Authority's Statements of Principles list cirrhosis of the liver as a factor. If DVA has accepted your cirrhosis of the liver, each of these has a documented pathway to a further claim.
At a glance
- Accepted conditionCirrhosis of the liver
- Conditions it may open17
- SourceRMA SoPs
- Chart Review$600 + GST
How a secondary claim works
Some Statement of Principles factors are not about service at all — they name another condition. Where DVA has already accepted your cirrhosis of the liver, and another condition's SoP lists cirrhosis of the liver as a factor, that part of the next claim is already established on your file. How a secondary claim works, in full →
Conditions that list cirrhosis of the liver as a factor
Quoted from the instrument. A pathway existing is not the same as a claim succeeding — each factor carries thresholds your record has to satisfy.
Cardiomyopathy
RH No. 57 of 2024 · BoP No. 58 of 2024
Reasonable Hypothesis — factor (14): “having cirrhosis of the liver before clinical onset or clinical worsening” [onset and worsening]
Balance of Probabilities — factor (12): “having cirrhosis of the liver before clinical onset or clinical worsening” [onset and worsening]
Cerebrovascular accident (stroke)
RH No. 45 of 2024 · BoP No. 46 of 2024
Reasonable Hypothesis — factor (31): “having cirrhosis of the liver or chronic liver disease at the time of clinical onset” [clinical onset]
Balance of Probabilities — factor (28): “having cirrhosis of the liver or chronic liver disease at the time of clinical onset” [clinical onset]
Cholelithiasis
RH No. 51 of 2016 · BoP No. 52 of 2016
Reasonable Hypothesis — factor (6): “having cirrhosis of the liver at the time of the clinical onset of cholelithiasis” [clinical onset] — factor (29): “having cirrhosis of the liver at the time of the clinical worsening of cholelithiasis; Veterans' Entitlements Act 1986” [worsening]
Balance of Probabilities — factor (6): “having cirrhosis of the liver at the time of the clinical onset of cholelithiasis; Veterans' Entitlements Act 1986” [clinical onset] — factor (26): “having cirrhosis of the liver at the time of the clinical worsening of cholelithiasis” [worsening]
Duodenal ulcer and duodenal erosion
RH No. 49 of 2024 · BoP No. 50 of 2024
Reasonable Hypothesis — factor (21): “having cirrhosis of the liver at the time of clinical onset or clinical worsening” [onset and worsening]
Balance of Probabilities — factor (16): “having cirrhosis of the liver at the time of clinical onset or clinical worsening” [onset and worsening]
Dupuytren disease
RH No. 9 of 2019 · BoP No. 10 of 2019
Reasonable Hypothesis — factor (4): “having cirrhosis of the liver or steatohepatitis before the clinical onset of Dupuytren disease” [clinical onset] — factor (17): “having cirrhosis of the liver or steatohepatitis before the clinical worsening of Dupuytren disease” [worsening]
This factor appears in the Reasonable Hypothesis instrument only, which applies to operational service.
Gallstone disease (cholelithiasis)
RH No. 69 of 2025 · BoP No. 70 of 2025
Reasonable Hypothesis — factor (18): “having cirrhosis of the liver at the time of clinical onset or clinical worsening” [onset and worsening]
Balance of Probabilities — factor (17): “having cirrhosis of the liver at the time of clinical onset or clinical worsening” [onset and worsening]
Gastric ulcer and gastric erosion
RH No. 51 of 2024 · BoP No. 52 of 2024
Reasonable Hypothesis — factor (23): “having cirrhosis of the liver at the time of clinical onset or clinical worsening” [onset and worsening]
Balance of Probabilities — factor (18): “having cirrhosis of the liver at the time of clinical onset or clinical worsening” [onset and worsening]
Hypogonadism
RH No. 73 of 2021 · BoP No. 74 of 2021
Reasonable Hypothesis — factor (18): “having cirrhosis of the liver at time of the clinical onset of hypogonadism” [clinical onset] — factor (56): “having cirrhosis of the liver at time of the clinical worsening of hypogonadism” [worsening]
Balance of Probabilities — factor (16): “having cirrhosis of the liver at time of the clinical onset of hypogonadism” [clinical onset] — factor (46): “having cirrhosis of the liver at time of the clinical worsening of hypogonadism” [worsening]
IgA NEPHROPATHY
RH No. 63 of 2021 · BoP No. 64 of 2021
Reasonable Hypothesis — factor (1): “having cirrhosis of the liver or chronic liver disease at the time of the clinical onset of IgA nephropathy” [clinical onset] — factor (8): “having cirrhosis of the liver or chronic liver disease at the time of the clinical worsening of IgA nephropathy” [worsening]
Balance of Probabilities — factor (1): “having cirrhosis of the liver or chronic liver disease at the time of the clinical onset of IgA nephropathy” [clinical onset] — factor (7): “having cirrhosis of the liver or chronic liver disease at the time of the clinical worsening of IgA nephropathy” [worsening]
Note: chronic liver disease is defined in the Schedule 1 - Dictionary.
Malignant neoplasm of the bile duct
RH No. 53 of 2024 · BoP No. 54 of 2024
Reasonable Hypothesis — factor (6): “having cirrhosis of the liver before clinical onset” [clinical onset]
Balance of Probabilities — factor (6): “having cirrhosis of the liver before clinical onset” [clinical onset]
Malignant neoplasm of the liver
RH No. 31 of 2020 · BoP No. 32 of 2020
Reasonable Hypothesis — factor (1): “having cirrhosis of the liver before the clinical onset of malignant neoplasm of the liver” [clinical onset]
Balance of Probabilities — factor (1): “having cirrhosis of the liver before the clinical onset of malignant neoplasm of the liver” [clinical onset]
Osteomyelitis
RH No. 23 of 2024 · BoP No. 24 of 2024
Reasonable Hypothesis — factor (6): “having one of the following chronic medical conditions before the clinical onset or clinical worsening of osteomyelitis: (a) chronic renal failure; (b) cirrhosis of the liver; (c) Crohn disease; or (d) sickle cell disorder” [onset and worsening]
Balance of Probabilities — factor (6): “having one of the following chronic medical conditions before the clinical onset or clinical worsening of osteomyelitis: (a) chronic renal failure; (b) cirrhosis of the liver; (c) Crohn disease; or (d) sickle cell disorder” [onset and worsening]
Note: chronic renal failure is defined in the Schedule -1 Dictionary.
Osteoporosis
RH No. 66 of 2024
Reasonable Hypothesis — factor (9): “having one of the following gastrointestinal diseases at the time of clinical onset or clinical worsening; (a) chronic exocrine pancreatic insufficiency; (b) cirrhosis of the liver; (c) coeliac disease; or (d) inflammatory bowel disease” [onset and worsening]
This factor appears in the Reasonable Hypothesis instrument only, which applies to operational service.
Parkinson's disease and secondary parkinsonism
RH No. 55 of 2016
Reasonable Hypothesis — factor (2): “for secondary parkinsonism only: (a) having an episode of acute cholinergic poisoning from exposure to an organophosphorus ester within the three months before the clinical onset of secondary parkinsonism; (b) having moderate to severe traumatic brain injury within the one year before the clinical onset of secondary parkinsonism; (c) having an intracranial space occupying lesion within the three months before the clinical onset of secondary parkinsonism; (d) having hydrocephalus, or draining of hydrocephalus, within the three months before the clinical onset of secondary parkinsonism; (e) having a cerebrovascular accident, excluding transient ischaemic attack, within the five years before the clinical onset of secondary parkinsonism; (f) having a disease from the specified list of diseases involving the cerebral vessels, in the presence of neuroimaging findings of brain stem or cerebral white matter lesions, haemorrhage or infarction, at the time of the clinical onset of secondary parkinsonism; (g) having a subarachnoid haemorrhage within the three months before the clinical onset of secondary parkinsonism; (h) having an acquired cerebrovascular malformation or dural arteriovenous fistula at the time of the clinical onset of secondary parkinsonism; (i) having an hypoxic cerebral insult within the two years before the clinical onset of secondary parkinsonism; (j) having influenza within the three months before the clinical onset of secondary parkinsonism; (k) having encephalitis within the three months before the clinical onset of secondary parkinsonism; (l) being infected with the human immunodeficiency virus before the clinical onset of secondary parkinsonism; Parkinson's Disease and Secondary Parkinsonism (Reasonable Hypothesis) (No. 55 of 2016) Veterans' Entitlements Act 1986 (m) having neurosyphilis at the time of the clinical onset of secondary parkinsonism; (n) having neurocysticercosis at the time of the clinical onset of secondary parkinsonism; (o) inhaling carbon disulphide vapour in an enclosed space, or having cutaneous contact with carbon disulphide, for a cumulative period of at least 500 hours, within the ten years before the clinical onset of secondary parkinsonism; (p) inhaling trichloroethylene vapour in an enclosed space, or having cutaneous contact with trichloroethylene, for a cumulative period of at least 2 000 hours, within the 20 years before the clinical onset of secondary parkinsonism; (q) inhaling or ingesting methanol or ethylene glycol, and having clinical, haematological or biochemical evidence of methanol or ethylene glycol intoxication, within the three months before the clinical onset of secondary parkinsonism; (r) being exposed to manganese as specified for a cumulative period of at least 250 hours, within the ten years before the clinical onset of secondary parkinsonism; (s) having clinical or biochemical evidence of manganese intoxication while receiving total parenteral nutrition or maintenance haemodialysis, at the time of the clinical onset of secondary parkinsonism; (t) inhaling, ingesting or having cutaneous contact with cyanide, and having clinical, haematological or biochemical evidence of cyanide intoxication, within the three months before the clinical onset of secondary parkinsonism; (u) having an injection containing 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) within the three months before the clinical onset of secondary parkinsonism; (v) using khat (Catha edulis), Ecstasy (3,4- methylenedioxymethamphetamine) or the drug methcathinone (ephedrone) within the three months before the clinical onset of secondary parkinsonism; Parkinson's Disease and Secondary Parkinsonism (Reasonable Hypothesis) (No. 55 of 2016) Veterans' Entitlements Act 1986 (w) taking a drug or a drug from a class of drugs from the specified list of drugs, for a continuous period of at least seven days within the three months before the clinical onset of secondary parkinsonism; (x) having a disorder of calcium metabolism from the specified list of disorders of calcium metabolism at the time of the clinical onset of secondary parkinsonism; (y) having cirrhosis of the liver at the time of the clinical onset of secondary parkinsonism; (z) having chronic renal failure at the time of the clinical onset of secondary parkinsonism; (aa) having a disease from the specified list of autoimmune diseases at the time of the clinical onset of secondary parkinsonism; or (bb) having a paraneoplastic encephalomyelitis at the time of the clinical onset of secondary parkinsonism” [clinical onset] — factor (28): “having cirrhosis of the liver at the time of the clinical worsening of Parkinson's disease or secondary parkinsonism; Parkinson's Disease and Secondary Parkinsonism (Reasonable Hypothesis) (No. 55 of 2016) Veterans' Entitlements Act 1986” [worsening]
This factor appears in the Reasonable Hypothesis instrument only, which applies to operational service.
Note: acute cholinergic poisoning and organophosphorus ester are defined in the Schedule 1 - Dictionary.
Porphyria cutanea tarda
RH No. 69 of 2021 · BoP No. 70 of 2021
Reasonable Hypothesis — factor (4): “having cirrhosis of the liver or steatohepatitis at the time of the clinical onset of porphyria cutanea tarda” [clinical onset] — factor (16): “having cirrhosis of the liver or steatohepatitis at the time of the clinical worsening of porphyria cutanea tarda” [worsening]
Balance of Probabilities — factor (4): “having cirrhosis of the liver or alcoholic steatohepatitis at the time of the clinical onset of porphyria cutanea tarda” [clinical onset] — factor (14): “having cirrhosis of the liver or alcoholic steatohepatitis at the time of the clinical worsening of porphyria cutanea tarda” [worsening]
Portal vein thrombosis
RH No. 107 of 2022 · BoP No. 108 of 2022
Reasonable Hypothesis — factor (1): “having cirrhosis of the liver at the time of the clinical onset of portal vein thrombosis” [clinical onset]
Balance of Probabilities — factor (1): “having cirrhosis of the liver at the time of the clinical onset of portal vein thrombosis” [clinical onset]
Tuberculosis
RH No. 47 of 2024 · BoP No. 48 of 2024
Reasonable Hypothesis — factor (8): “having cirrhosis of the liver at the time of the clinical worsening of tuberculosis” [worsening]
Balance of Probabilities — factor (8): “having cirrhosis of the liver at the time of the clinical worsening of tuberculosis” [worsening]
Other accepted conditions that also open cardiomyopathy
If any of these is also on your file, it reaches some of the same conditions cirrhosis of the liver does.
What DVA means by cirrhosis of the liver
A claim is tested against the definition first. If the diagnosis on your file does not meet this wording, the factors below never get reached — so it is worth checking that what your doctor wrote matches what the instrument requires.
Cirrhosis of the liver, for the purposes of the Statement of Principles, for the purposes of this Statement of Principles, cirrhosis of the liver means a chronic condition of the hepatic parenchyma involving severe fibrosis in association with the formation of regenerative nodules. (3) While cirrhosis of the liver attracts ICD-10-AM code K70.3, K71.7 or K74.3-K74.6, in applying this Statement of Principles the meaning of cirrhosis of the liver is that given in subsection (2). (4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Ninth Edition, effective date of 1 July 2015, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-020-5.
Aggravation-only factors. In this instrument, subsections 9(28) to 9(55) apply only to material contribution to, or aggravation of, cirrhosis of the liver where it was already present before or during service. If service caused cirrhosis of the liver outright, those factors are not available to you.
RH No. 1 of 2017 · BoP No. 2 of 2017 · 51 factors
What could support a claim for cirrhosis of the liver?
The Statement of Principles for cirrhosis of the liver names 5 other conditions among its own factors. If any of these is already accepted on your file, it may be the factor that carries a cirrhosis of the liver claim — quoted here from the instrument.
Hepatitis B
Reasonable Hypothesis — factor (4): “having chronic infection with the hepatitis B virus before the clinical onset of cirrhosis of the liver” [clinical onset]
Reasonable Hypothesis — factor (8): “having chronic hepatitis before the clinical onset of cirrhosis of the liver” [clinical onset]
Hepatitis C
Reasonable Hypothesis — factor (5): “having chronic infection with the hepatitis C virus before the clinical onset of cirrhosis of the liver” [clinical onset]
Reasonable Hypothesis — factor (32): “having chronic infection with the hepatitis C virus before the clinical worsening of cirrhosis of the liver” [worsening]
Hepatitis D
Reasonable Hypothesis — factor (6): “having chronic infection with the hepatitis D virus before the clinical onset of cirrhosis of the liver” [clinical onset]
Reasonable Hypothesis — factor (33): “having chronic infection with the hepatitis D virus before the clinical worsening of cirrhosis of the liver” [worsening]
Steatohepatitis
Reasonable Hypothesis — factor (10): “having steatohepatitis before the clinical onset of cirrhosis of the liver” [clinical onset]
Reasonable Hypothesis — factor (37): “having steatohepatitis before the clinical worsening of cirrhosis of the liver” [worsening]
Alpha-1 antitrypsin deficiency
Reasonable Hypothesis — factor (18): “having alpha-1 antitrypsin deficiency before the clinical onset of cirrhosis of the liver” [clinical onset]
Reasonable Hypothesis — factor (45): “having alpha-1 antitrypsin deficiency before the clinical worsening of cirrhosis of the liver” [worsening]
Reviewed by Dr Thomas Perkins
Founding doctor, Veterans Health Centre · former RAAF aviation medical officer · 13 years working exclusively with ADF members and veterans. Full profile →
Cirrhosis of the liver accepted?
Contact us for more information.